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Reproducibility – the ability to recompute results – and replicability – the chances other experimenters 
will achieve a consistent result – are two foundational characteristics of successful scientific research. 
Consistent findings from independent investigators are the primary means by which scientific evidence 
accumulates for or against an hypothesis. And yet, of late there has been a crisis of confidence among 
researchers worried about the rate at which studies are either reproducible or replicable. In order to 
maintain the integrity of science research and maintain the public’s trust in science, the scientific 
community must ensure reproducibility and replicability by engaging in a more preventative approach that 
greatly expands data analysis education and routinely employs software tools.  
 
We define reproducibility as the ability to recompute data analytic results given an observed data set and 
knowledge of the data analysis pipeline. The replicability of a study is the chance that an independent 
experiment targeting the same scientific question will produce a consistent result (1). Concerns among 
scientists about both have gained significant traction recently due in part to a statistical argument that 
suggested most published scientific results may be false positives (2). At the same time, there have been 
some very public failings of reproducibility across a range of disciplines from cancer genomics (3) to 
economics (4), and the data for many publications have not been made publicly available, raising doubts 
about the quality of data analyses. Popular press articles have raised questions about the reproducibility of 
all scientific research (5) and the United States Congress has convened hearings focused on the 
transparency of scientific research (6). The result is that much of the scientific enterprise have been called 
into question, putting at risk funding and hard won scientific truths. 
 
From a computational perspective, there are three major components to a reproducible and replicable 
study: (a) the raw data from the experiment are available, (b) the statistical code and documentation to 
reproduce the analysis are available, and (c) a correct data analysis must be performed. Recent cultural 
shifts in genomics and other areas have had a positive impact on data and code availability. Journals are 
starting to require data availability as a condition for publication (7) and centralized databases such as the 
NCBI’s GEO are being created for depositing data generated by publicly funded scientific experiments. 
New computational tools such as knitr, iPython notebook, LONI, and Galaxy have simplified the process 
of distributing reproducible data analyses. 
 
Unfortunately, the mere reproducibility of computational results is insufficient to address the replication 
crisis because even a reproducible analysis can suffer from many problems—confounding from omitted 
variables, poor study design, missing data—that threaten the validity and useful interpretation of the 
results. While improving the reproducibility of research may increase the rate at which flawed analyses 
are uncovered, as recent high-profile examples have demonstrated, it does not change the fact that 
problematic research is conducted in the first place. 
 
The key question we want to answer when seeing the results of any scientific study is “Can I trust this 
data analysis?” If we think of problematic data analysis as a disease, reproducibility speeds diagnosis and 
treatment in the form of screening and rejection of poor data analyses by referees, editors, and other 
scientists in the community (Figure 1).  
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Figure 1: Education and evidence-based data analysis as prevention. Peer review and editor 
evaluation are treatments for poor data analysis. Education and evidence-based data analysis can 
be thought of as prevention. 
This “medication” approach to research quality relies on peer reviewers and editors to make this diagnosis 
consistently—this is a tall order. Editors and peer reviewers at medical and scientific journals often lack 
the training and time to perform a proper evaluation of a data analysis. This problem is compounded by 
the fact that data sets and data analyses are becoming increasingly complex, the rate of submission to 
journals continues to increase (8), and the demands on statisticians to referee are increasing. These 
pressures have reduced the efficacy of peer review in identifying and correcting potential false discoveries 
in the medical literature. And, crucially, the medication approach does not address the problem at its 
source.  
 
We suggest that the replication crisis needs to be considered from the perspective of primary prevention. 
If we can prevent problematic data analyses from being conducted, we can substantially reduce the burden 
on the community of having to evaluate an increasingly heterogeneous and complex population of studies 
and research findings. The best way to prevent poor data analysis in the scientific literature is to 
(a) increase the number of trained data analysts in the scientific community and (b) identify statistical 
software and tools that can be shown to improve reproducibility and replicability of studies.  
 
How can we dramatically scale up data science education in the short term? One approach that we have 
taken is through Massive Online Open Courses (MOOCs). The Johns Hopkins Data Science 
Specialization (http://jhudatascience.org/) is a sequence of 9 courses covering the full spectrum of data 
science skills from formulating quantitative questions, to cleaning data, to statistical analysis and 
producing reproducible reports. So far we have enrolled over 1.5 million students in this Specialization. A 
complementary approach is crowd-sourced short courses such as Data and Software Carpentry 
(http://software-carpentry.org/) that have addressed the extreme demand for data science knowledge on a 
smaller scale. But simply increasing data analytic literacy comes at a cost. Most scientists in these 
programs will receive basic to moderate training in data analysis, creating the potential for producing 
individuals with enough skill to perform data analysis but without enough knowledge to prevent mistakes.  
 
To improve the global robustness of scientific data analysis, we must couple education efforts with the 
identification of data analytic strategies that are most reproducible and replicable in the hands of basic or 
intermediate data analysts. Statisticians must bring to bear their history of developing rigorous methods to 
the area of data science. A fundamental component of scaling up data science education is performing 
empirical studies to identify statistical methods, analysis protocols, and software that lead to increased 
replicability and reproducibility in the hands of users with basic knowledge. We call this approach 
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evidence-based data analysis. Just as evidence-based medicine applies the scientific method to the 
practice of medicine, evidence-based data analysis applies the scientific method to the practice of data 
analysis. Combining massive scale education with evidence-based data analysis can allow us to quickly 
test data analytic practices in a population most at risk for data analytic mistakes (9).  
 
In much the same way that epidemiologist John Snow ended a London cholera epidemic by 
removing a pump handle to make contaminated water unavailable we have an opportunity to 
attack the crisis of scientific reproducibility at its source. Dramatic increases in data science 
education, coupled with robust evidence-based data analysis practices, have the potential to 
prevent problems with reproducibility and replication before they can cause permanent damage 
to the credibility of science.  
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